Skip to main navigation Skip to search Skip to main content

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

  • Antonis C. Antoniou
  • , Amanda B. Spurdle
  • , Olga M. Sinilnikova
  • , Sue Healey
  • , Karen A. Pooley
  • , Rita K. Schmutzler
  • , Beatrix Versmold
  • , Christoph Engel
  • , Alfons Meindl
  • , Norbert Arnold
  • , Wera Hofmann
  • , Christian Sutter
  • , Dieter Niederacher
  • , Helmut Deissler
  • , Trinidad Caldes
  • , Kati Kämpjärvi
  • , Heli Nevanlinna
  • , Jacques Simard
  • , Jonathan Beesley
  • , Xiaoqing Chen
  • Susan L. Neuhausen, Timothy R. Rebbeck, Theresa Wagner, Henry T. Lynch, Claudine Isaacs, Jeffrey Weitzel, Patricia A. Ganz, Mary B. Daly, Gail Tomlinson, Olufunmilayo I. Olopade, Joanne L. Blum, Fergus J. Couch, Paolo Peterlongo, Siranoush Manoukian, Monica Barile, Paolo Radice, Csilla I. Szabo, Lutecia H.Mateus Pereira, Mark H. Greene, Gad Rennert, Flavio Lejbkowicz, Ofra Barnett-Griness, Irene L. Andrulis, Hilmi Ozcelik, Anne Marie Gerdes, Maria A. Caligo, Yael Laitman, Bella Kaufman, Roni Milgrom, Eitan Friedman, Susan M. Domchek, Katherine L. Nathanson, Ana Osorio, Gemma Llort, Roger L. Milne, Javier Benítez, Ute Hamann, Frans B.L. Hogervorst, Peggy Manders, Marjolijn J.L. Ligtenberg, Ans M.W. van den Ouweland, Susan Peock, Margaret Cook, Radka Platte, D. Gareth Evans, Rosalind Eeles, Gabriella Pichert, Carol Chu, Diana Eccles, Rosemarie Davidson, Fiona Douglas, Andrew K. Godwin, Laure Barjhoux, Sylvie Mazoyer, Hagay Sobol, Violaine Bourdon, François Eisinger, Agnès Chompret, Corinne Capoulade, Brigitte Bressac-de Paillerets, Gilbert M. Lenoir, Marion Gauthier-Villars, Claude Houdayer, Dominique Stoppa-Lyonnet, Georgia Chenevix-Trench, Douglas F. Easton
  • Cancer Research UK Program
  • Peter Maccallum Cancer Centre
  • Queensland Institute of Medical Research
  • Centre de Recherche en Cancérologie de Lyon
  • Universite Claude Bernard Lyon 1
  • University of Cologne
  • Leipzig University
  • Technical University of Munich
  • Kiel University
  • Charité – Universitätsmedizin Berlin
  • Heidelberg University 
  • Heinrich Heine University Düsseldorf
  • Ulm University
  • Hospital Clínico San Carlos de Madrid
  • Helsinki University Hospital
  • Université Laval
  • University of California at Irvine
  • University of Pennsylvania
  • University of Vienna
  • Creighton University
  • Georgetown University
  • City of Hope National Medical Center
  • University of California at Los Angeles
  • University of Texas at Dallas
  • University of Chicago
  • Baylor Health Care System
  • Mayo Clinic
  • Fondazione IRCCS Istituto Nazionale dei Tumori
  • IRCCS Istituto Europeo di Oncologia - Milano
  • Mayo Clinic College of Medicine and Science
  • National Institutes of Health
  • Clalit Health Services
  • Cancer Care Ontario
  • University of Toronto
  • University of Southern Denmark
  • University of Pisa
  • The Gertner Institute
  • Sheba Medical Center at Tel Hashomer
  • Biomedical Network on Rare Diseases (CIBERER)
  • Institute Catala Oncologia
  • German Cancer Research Center
  • Netherlands Cancer Institute
  • Radboud University Nijmegen
  • Erasmus University Rotterdam
  • Imperial College Healthcare NHS Trust
  • Royal Marsden Hospital
  • King's College London
  • Yorkshire Regional Genetics Service
  • University Hospital Southampton NHS Foundation Trust
  • Ferguson-Smith Centre for Clinical Genetics
  • Centre for Life
  • Fox Chase Cancer Center
  • Institut national de la santé et de la recherche médicale
  • Université Paris-Sud
  • Institut Curie

Research output: Contribution to journalArticlepeer-review

252 Scopus citations

Abstract

Germline mutations in BRCA1 and BRCA2 confer high risks of breast cancer. However, evidence suggests that these risks are modified by other genetic or environmental factors that cluster in families. A recent genome-wide association study has shown that common alleles at single nucleotide polymorphisms (SNPs) in FGFR2 (rs2981582), TNRC9 (rs3803662), and MAP3K1 (rs889312) are associated with increased breast cancer risks in the general population. To investigate whether these loci are also associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers, we genotyped these SNPs in a sample of 10,358 mutation carriers from 23 studies. The minor alleles of SNP rs2981582 and rs889312 were each associated with increased breast cancer risk in BRCA2 mutation carriers (per-allele hazard ratio [HR] = 1.32, 95% CI: 1.20-1.45, ptrend = 1.7 × 10-8 and HR = 1.12, 95% CI: 1.02-1.24, ptrend = 0.02) but not in BRCA1 carriers. rs3803662 was associated with increased breast cancer risk in both BRCA1 and BRCA2 mutation carriers (per-allele HR = 1.13, 95% CI: 1.06-1.20, ptrend = 5 × 10-5 in BRCA1 and BRCA2 combined). These loci appear to interact multiplicatively on breast cancer risk in BRCA2 mutation carriers. The differences in the effects of the FGFR2 and MAP3K1 SNPs between BRCA1 and BRCA2 carriers point to differences in the biology of BRCA1 and BRCA2 breast cancer tumors and confirm the distinct nature of breast cancer in BRCA1 mutation carriers.

Original languageEnglish
Pages (from-to)937-948
Number of pages12
JournalAmerican Journal of Human Genetics
Volume82
Issue number4
DOIs
StatePublished - Apr 11 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adult
  • Aged
  • Breast Neoplasms/genetics
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Genetic Predisposition to Disease/genetics
  • Germ-Line Mutation
  • Humans
  • MAP Kinase Kinase Kinase 1/genetics
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Receptor, Fibroblast Growth Factor, Type 2/genetics
  • Risk

Fingerprint

Dive into the research topics of 'Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers'. Together they form a unique fingerprint.

Cite this